Skip to main content

Table 3 Relationship Between Intratumoral and Peritumoral ZBTB20 and Clinicopathologic Features

From: Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis

 

Intratumoral ZBTB20

 

Peritumoral ZBTB20

 

Variable

High

(n = 42, 41.2%)

Low

(n = 60, 58.8%)

P

High

(n = 42, 41.2%)

Low

(n = 60, 58.8%)

P

Age(years)

  

0.523

  

1.0

   ≤50

19

31

 

20

30

 

   >50

23

29

 

22

30

 

Gender

  

0.188

  

0.188

   Male

36

45

 

36

45

 

   Female

6

15

 

6

15

 

Tumor size(mm)

  

0.299

  

0.550

   ≤50

10

20

 

11

19

 

   >50

32

40

 

31

41

 

AFP(ng/ml)

      

   ≤20

10

16

0.745

11

15

0.892

   >20

32

44

 

31

45

 

HBsAg

  

0.302

  

0.106

   Positive

38

50

 

39

49

 

   Negtive

4

10

 

3

11

 

Pathological stage

  

0.396*

  

1.0*

   I-II

1

5

 

2

4

 

   III-IV

41

55

 

40

56

 

Liver cirrhosis

  

0.675

  

0.172

   Yes

31

42

 

27

46

 

   No

11

18

 

15

14

 

Tumor encapsulation

  

0.235

  

0.446

   Complete

12

27

 

13

26

 

   Uncomplete

10

10

 

9

11

 

   No

20

23

 

20

23

 

Vein invasion

  

0.016

  

0.161

   Present

13

7

 

11

9

 

   Absent

29

53

 

31

51

 

Tumour multiplicity

  

0.064

  

0.589

   Solitary

25

46

 

28

43

 

   Multiple

17

14

 

14

17

 

TNM stage

  

0.07

  

0.573

   I-II

22

5

 

25

39

 

   III

20

55

 

17

21

 

Recurrence

  

0.003

  

0.001

   Yes

37

37

 

38

36

 

   No

5

23

 

4

24

 

Metastasis

  

0.000

  

0.08

   Yes

27

16

 

22

21

 

   No

15

44

 

20

39

 
  1. Abbreviations: HBsAg, hepatitis B s antigen.
  2. *Twenty-five percent of all the cells have expected count less than 5; Fisher's exact test.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us